About TheraRadar

TheraRadar started as a set of scripts I wrote for myself — pulling IBD targets, drugs, and companies from the FDA, Open Targets, and ClinicalTrials.gov. It was personal curiosity at first, but the workflow quickly outgrew the IBD use case.

Today the same workflow connects every FDA-approved drug and biological target to its active trials, patent landscape, and SEC disclosures — refreshed weekly. Briefs sit on top: long-form pieces that aim to tell data-driven stories about what the science changes — and what the market makes of it.

It's the tool I wanted to exist when I was doing this work myself.

I'm Narayanan, a computational biologist with nearly two decades of post-PhD experience spanning pharma, genomics research, and academia. Most recently, I worked as Senior Principal Scientist at Bristol Myers Squibb, where I supported discovery programs in cardiovascular disease, fibrosis, and immunology, along with translational and reverse-translational efforts in immunoscience and neuroscience — drawing on internal, collaborative, biobank, and real-world datasets.

Through Tensoromics, I run an independent computational biology consulting practice working with biotech and pharma teams on omics analysis, biomarker analysis, and target discovery.

TheraRadar is built and operated under Tensoromics, a computational biology consulting company helping biotech and pharma teams.

Product questions, partnerships, or Brief tips: hello@theraradar.com.

Consulting inquiries: via tensoromics.com.

For details on the data sources powering TheraRadar — FDA Drugs@FDA, ClinicalTrials.gov, SEC EDGAR, and the rest — see the Data Sources & Methodology page.

On accounts: when you sign in, we record the 2-letter country code your browser connects from (via Cloudflare) so we can see roughly where users come from. We do not store IP addresses, cities, or movement over time.